After-Hours Stock Movers 07/09: (DELL) (TCRD) (VMW) Higher; (EDIT) (TELA) (SLNO) Lower (more...)

After-Hours Stock Movers

DAVIDsTEA Inc. (Nasdaq: DTEA) 18.4% HIGHER; announces that further to obtaining an Initial Order pursuant to the Companies’ Creditors Arrangement Act (Canada) (“CCAA”) from the Quebec Superior Court in order to implement its restructuring plan, the Company is sending notices to terminate leases for 82 of its stores in Canada and all 42 of its stores in the United States. The lease terminations will take effect in 30 days.

Matson, Inc. (NYSE: MATX) 16.8% HIGHER; announces preliminary second quarter financial results, provides a business update and announces second quarter earnings call date.

Ziopharm Oncology, Inc. (NASDAQ: ZIOP) 8.6% LOWER; announced the initiation of a phase 1 clinical trial to evaluate CD19-specific CAR-T, using its Rapid Personalized Manufacturing (RPM) technology, as an investigational treatment for patients with relapsed CD19+ leukemias and lymphomas. The trial is now open for enrollment at The University of Texas MD Anderson Cancer Center.

Franklin Covey (NYSE: FC) 8.6% LOWER; reported Q3 EPS of ($0.79), $0.49 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $37.1 million versus the consensus estimate of $48.88 million.

Simulations Plus (NASDAQ: SLP) 6.5% HIGHER; reported Q3 EPS of $0.16, $0.07 better than the analyst estimate of $0.09. Revenue for the quarter came in at $12.3 million versus the consensus estimate of $11.21 million.

PriceSmart (NASDAQ: PSMT) 5.8% HIGHER; reported Q3 EPS of $0.41, $0.15 better than the analyst estimate of $0.26. Revenue for the quarter came in at $799.93 million versus the consensus estimate of $693.45 million.

Spartan Energy Acquisition (NYSE: SPAQ) 5.7% HIGHER; adds to 39% intra-day gains on reports it is in the lead to acquire EV maker Fisker.

WD-40 Co. (NASDAQ: WDFC) 4.2% LOWER; reported Q3 EPS of $1.06, $0.01 worse than the analyst estimate of $1.07. Revenue for the quarter came in at $98.2 million versus the consensus estimate of $108.1 million.

Redfin Corp. (NASDAQ: RDFN) 1.9% LOWER; RBC Capital downgraded from Outperform to Sector Perform with a price target of $41.00.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• AptarGroup (ATR) Tops Q1 EPS by 11c
• Utah Medical Products (UTMD) Reports Q1 EPS of $1.10